Stenabolic (SR 9009) 10mg/60caps PEPTIDE PHARM

What Is SR9009?

SR9009 is a laboratory-developed compound that has attracted attention in scientific research for its possible performance-related properties. Although it is sometimes mentioned alongside SARMs due to similar research interests, SR9009 actually belongs to a different category. It functions as a Rev-ErbA (circadian nuclear receptor) agonist, rather than a selective androgen receptor modulator.

The Rev-ErbA receptor is a protein present in several tissues throughout the body, including the liver, brain, fat tissue, and skeletal muscles. In experimental settings, SR9009 has been shown to stimulate this receptor, which may play a role in regulating metabolism and supporting cardiovascular function under controlled laboratory conditions.

Because SR9009 is considered non-hormonal, research suggests that it may not directly influence the endocrine system in the same way as hormone-related compounds. However, it is important to note that the available evidence comes mainly from laboratory or animal studies, and SR9009 has not been approved for human consumption.

How SR9009 Works

SR9009 has been studied as a compound that activates the Rev-ErbA receptor, influencing how this protein functions in different tissues.

In laboratory experiments, activation of this receptor has been linked to an increase in mitochondrial activity and density in skeletal muscle cells. In animal studies, this effect has been associated with outcomes resembling improved endurance capacity.

Research also suggests that stimulation of Rev-ErbA receptors in the liver and fat tissue may influence lipid metabolism. Some experimental findings indicate that SR9009 may affect genes involved in fat storage and lipid utilization, potentially leading to reduced fat accumulation under specific research conditions.